Back

AACR-NCI-EORTC 2022 - AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oct 26 - Oct 28, 2022 | BarcelonaSpain

LARVOL is not affiliated with AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and all trademarks, logos, and brand names are property of their respective owners

Top Trials

Showing 78 abstracts linked to Trials

16; PB002 - Predicting response to naratuximab emtansine, an anti-CD37 antibody-drug conjugate (ADC), in combination with rituximab in Diffuse Large B Cell Lymphoma (DLBCL), by analyzing the spatial arrangement of CD37 and CD20 positive cells using deep learning

  • Poster

17; PB003 - BAY 2927088: The first non-covalent, potent, and selective tyrosine kinase inhibitor targeting EGFR exon 20 insertions and C797S resistance mutations in NSCLC

  • Poster